企業(yè)檔案
- 會(huì)員類型:免費(fèi)會(huì)員
- 工商認(rèn)證: 【已認(rèn)證】
- 最后認(rèn)證時(shí)間:
- 法人:
- 注冊(cè)號(hào):
- 企業(yè)類型:經(jīng)銷商
- 注冊(cè)資金:人民幣萬
聯(lián)系我們
聯(lián)系人:李
熱門標(biāo)簽
技術(shù)文章
利培酮和9-羥基利培酮的快速固相萃取和分析certify.pdf
利培酮和9-羥基利培酮的快速固相萃取和分析
Risperidone (RISP) is an atypical anti-psychotic agent commonly used
to manage psychotic patients. One unique feature of Risperidone is that
its metabolite, 9-Hydroxyrisperidone (OH-RISP) is as active as
Risperidone, and clinically the sum of the Risperidone and 9-
Hydroxyrrisperidone plasma concentration has been used as a means
to monitor efficacy and toxicity [1]. The therapeutic concentration level
is 2-20 μg/L for Risperidone and 10-100 μg/L for 9-Hydroxyrisperidone
respectively. The symptoms of the overdose are daze, sedation, tachycardia,
hypotension and extrapyramidal effects [2].
Monitoring of RISP and OH-RISP concentrations in plasma is an
important parameter in pharmacokinetic and toxicology laboratories.
A fast and highly reproducible analytical method with low
detection limits is very important.
This paper shows the determination of the plasma concentration of
RISP/OH-RISP with reversed phase LC-MS after fast automated solid
phase extraction (SPE). The SPE sorbent used was a mixed-mode
phase which gives extra clean extracts and high recovery values.
原創(chuàng)作者:泉島公司--色譜消耗品專家